Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice.

about

Drug interactions with aprepitant or fosaprepitant: Review of literature and implications for clinical practice.Assessment of Oral Anticoagulant Use in Residents of Long-Term Care Homes: Evidence for Contemporary Suboptimal Use.

P2860

Q38752456-3ED379F9-23E0-4F78-A26F-4AB97F48F827 Q39458922-90D244C3-D5D9-42B1-9D92-9E3305C518CE

P2860

Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice.

Item

http://www.wikidata.org/entity/Q38496232

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Use of Non-Vitamin K Antagonis ...... lication to Clinical Practice.

@en

type

Item

label

Use of Non-Vitamin K Antagonis ...... lication to Clinical Practice.

@en

prefLabel

Use of Non-Vitamin K Antagonis ...... lication to Clinical Practice.

@en

P1476

Use of Non-Vitamin K Antagonis ...... lication to Clinical Practice.

@en

P2093

Anastasia Rivkin

http://www.w3.org/2001/XMLSchema#string

Antonia Carbone

http://www.w3.org/2001/XMLSchema#string

Gail B Rattinger

http://www.w3.org/2001/XMLSchema#string

Jesse Sullivan

http://www.w3.org/2001/XMLSchema#string

Julie Kalabalik

http://www.w3.org/2001/XMLSchema#string

Malgorzata Slugocki

http://www.w3.org/2001/XMLSchema#string

P2860

Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Warfarin: almost 60 years old and still causing problems

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects

Dabigatran versus warfarin in patients with atrial fibrillation

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity

Dabigatran versus warfarin in patients with mechanical heart valves

Validation of Clinical Classification Schemes for Predicting Stroke

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

P2888

s40265-015-0405-y

P304

979-998

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-015-0405-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1012905469

http://www.w3.org/2001/XMLSchema#string

P698

25998374

http://www.w3.org/2001/XMLSchema#string

P921

vitamin K

anticoagulation

Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice.

about

P2860

P2860

Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921